2023年3月14日

分享4000万美元投资，开发和扩大加拿大制造的手术机器人、核磁共振成像和医疗成像和手术室数据平台。Synaptive技术已在20个国家的120家医疗机构安装，并计划在2023年及以后继续创新。新立得医疗是一家位于加拿大的全球医疗技术创新者，从加拿大出口信贷机构加拿大出口发展局(EDC)获得了4000万美元的投资。EDC领投5000万美元融资，以加速新立得的专利创新投资组合。来自EDC的承诺将提高新立得的开发和商业能力，同时扩大临床医生对该公司完全集成技术的访问。这一合作关系符合EDC中端市场增长业务的使命，即帮助加拿大领先的中端市场科技公司加速扩张，这些公司的定位是提高加拿大在全球市场上的国际竞争力。新立得是一家高增长、创新的公司，提供尖端的医疗保健产品和解决方案。EDC中端市场集团高级副总裁Guillermo Freire表示:“他们具有高度颠覆性，市场领先的技术能够改善患者的治疗结果，同时为所有医疗保健系统利益相关者提供令人信服的利益。”“EDC高度专注于支持未来关键领域的新兴全球冠军企业。通过投资新立得，EDC正在支持加速采用重要技术，促进全球人类福祉事业。” Related Posts Developed and manufactured in Canada, the company’s products include a surgical digital robotic exoscope, integrative data platforms and comprehensive imaging technology. Synaptive’s devices are connecting clinicians in operating rooms across mid-field MRI, surgical planning and surgical visualization platforms. Synaptive’s fully integrated surgical suite includes Modus™ V, Modus™ Nav, Modus™ Plan, and mid-field MRI. Each product automates critical patient data through every step of surgical intervention. Modus™ V, a robotic exoscope, seamlessly combines optics and video processing breakthroughs for a revamped surgical operating experience. Additionally, Synaptive’s mid-field MRI supports faster and earlier detection of neurological deficits. “We are very happy to have EDC as a key part of the Synaptive team”, said Cameron Piron, President and Co-founder of Synaptive Medical. “This investment allows us to expand rapidly and is well timed with our most exciting product releases to date. Our shared vision and purpose are to provide our industry leading and patient focused technologies to as many people as we can globally.”